Hipra will carry out a so-called Phase II trial, on the volunteers

Hipra will carry out a so-called Phase II trial, on the volunteers. | Javier Cebollada

ReutersMadrid15/11/2021 13:09
TW
0

Spain's health regulator has authorised Spanish pharmaceutical group Hipra to test the COVID-19 vaccine it is developing on more than 1,000 volunteers, Prime Minister Pedro Sanchez said on Monday.

Related news
Restaurant in Mallorca during the pandemic

Pandemic compensation claims by Mallorcan companies rejected by Spain's Supreme Court

More related news

Hipra will carry out a so-called Phase II trial - the second stage of a three-round trial process, on the volunteers, Sanchez said.